Aravax is a clinical-stage biotechnology company developing the first safe and rapidly effective treatment for peanut allergy.
Clinical Trials

Clinical trial AVX-001 is the first study of PVX108 to be conducted in humans.

Please reload

Recent News

Aravax


Tel: +61 (0)3 9657 0700
Email: info@aravax.com.au​
Address: Level 9, 31 Queen St

Melbourne, Victoria, 3000

Australia

Contact Us